This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2010 Mar 15;50(6):840-2.

doi: 10.1086/650577.

Challenges in reintroducing tuberculosis medications after hepatotoxicity

Jussi Saukkonen

PMID: 20156056
DOI: 10.1086/650577

Editorial

Challenges in reintroducing tuberculosis medications after hepatotoxicity

Jussi Saukkonen. Clin Infect Dis. 2010.

. 2010 Mar 15;50(6):840-2.

doi: 10.1086/650577.

Author

Jussi Saukkonen

PMID: 20156056
DOI: 10.1086/650577

No abstract available

PubMed Disclaimer

Comment on

Safety of 3 different reintroduction regimens of antituberculosis drugs after development of antituberculosis treatment-induced hepatotoxicity.
Sharma SK, Singla R, Sarda P, Mohan A, Makharia G, Jayaswal A, Sreenivas V, Singh S. Sharma SK, et al. Clin Infect Dis. 2010 Mar 15;50(6):833-9. doi: 10.1086/650576. Clin Infect Dis. 2010. PMID: 20156055 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information